Core Viewpoint - The company aims to optimize its asset structure by gradually divesting non-core assets to focus on its main business, particularly in the natural mineral water sector, as part of its long-term development strategy [1] Group 1: Asset Divestiture - The company plans to publicly transfer 100% equity of its park landscaping subsidiary through the "Jilin Changchun Property Rights Trading Center" [1] - This divestiture is part of the company's strategy to strengthen its development framework centered on the forest health industry [1] - The transfer process will involve information disclosure and soliciting potential buyers via a property trading platform after obtaining approval from the relevant state-owned asset regulatory authority [1] Group 2: Corporate Governance - The company's 10th Board of Directors held a temporary meeting on January 16, 2026, where the proposal for the public transfer of the subsidiary's 100% equity was approved [1] - The equity transfer is subject to approval from the higher-level state-owned asset supervisory unit, Jilin Changbai Mountain Forestry Group [1]

Core Viewpoint - The company has successfully transformed from traditional forestry to a green health industry, focusing on natural mineral water as its core business while expanding into landscaping, wood doors, specialty foods, and forestry carbon sinks [1][2]. Group 1: Financial Performance - In Q1 2025, the company achieved operating revenue of 307 million yuan, a year-on-year increase of 31.74% [2] - The net profit for Q1 2025 was 5.11 million yuan, marking a turnaround from a loss to profit [2] - The non-recurring net profit was 1.38 million yuan, also indicating a shift from loss to profit year-on-year [2] Group 2: Business Strategy and Market Position - The increase in operating revenue is primarily attributed to the rise in sales volume of natural mineral water [2] - The company’s main products in the natural mineral water segment are low mineralization water rich in silicic acid, with a weak alkaline pH, and the company has developed maternal and infant water products [2] - The company is positioned to benefit from the overall growth in the big consumption and big health industries, despite potential short-term economic impacts [3] Group 3: Market Management and Future Outlook - The company plans to actively promote its market value management in accordance with regulatory guidelines issued by the China Securities Regulatory Commission and the State-owned Assets Supervision and Administration Commission [3] - The company aims to enhance its competitive strength through continuous reform and mechanism-driven initiatives [3]